U.S. Markets closed

Technology Platforms and Research Programs Drive LGND’s Partnerships

Margaret Patrick

Ligand Pharmaceuticals (LGND) has entered multiple fully funded partnerships by licensing its technology platforms such as OmniAb, Captisol, LTP Technology, and SUREtechnology Platform.